DELcore offers an unparalleled premium, exclusive partnership that drives rapid, high-impact drug discovery. Partners access X-Chem’s most expansive DNAencoded libraries (DEL)—over 225 billion molecules of proprietary chemistries designed for hit identification.

As a DELcore partner, you have the unique opportunity to own the exclusive rights to the active compounds identified during the discovery process. This gives you the ability to develop these compounds as part of your own portfolio, ensuring full control over your discoveries and future therapeutic development.